tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Stock Investors

Compare
578 Followers
Based on 791,381 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold VERV
On average, investors allocate 2.73% of their portfolios to VERV
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 791,381 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VERV

<0.1%
Last 7
Days
1.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VERV, out of 791,381 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VERV Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.67%
$7.61
Increased
3.98%
$7.03
Based on the activity of investors who made their portfolios public
The table shows changes in VERV in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VERV Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
UiPath
3.37%
-1.19%
-7.77%
6.45B
Technology
Plug Power
4.98%
-1.00%
-5.87%
1.55B
Industrials
Block
3.62%
+1.33%
-0.21%
34.25B
Technology
Lucid Group
5.41%
-0.72%
-2.58%
6.34B
Consumer Cyclical
Recursion Pharmaceuticals
3.34%
-0.63%
+0.80%
2.44B
Healthcare
Intuitive Surgical
3.60%
+0.24%
-0.94%
176.09B
Healthcare
Fortinet
3.61%
+0.06%
-1.04%
75.57B
Technology
Trade Desk
3.40%
+0.95%
+13.01%
29.19B
Technology
Nio
9.10%
-0.29%
-5.35%
10.15B
Consumer Cyclical
Riot Platforms
4.69%
-0.44%
-7.07%
2.70B
Financial
Based on the activity of 791,381 active portfolios
Open your Smart Portfolio

VERV Investor Analysis

VERV investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.0%
of VERV holders
are under 35
Average Segment Performance
Average P/E Ratio19.03
Beta11.09
Dividend Yield3.88%
VERV investors between 35–55

Between 35–55

7.3%
Last 30 days
Holdings Change
53.0%
of VERV holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.53
Beta21.54
Dividend Yield3.37%
VERV investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.0%
of VERV holders
are over 55
Average Segment Performance
Average P/E Ratio14.83
Beta10.65
Dividend Yield3.62%
Overview of age group and performance of VERV stock investors
See who invests in VERV according to age group and performance.

FAQ

How many retail Investors hold VERV?
<0.1% of TipRanks' retail investors hold VERV in their portfolios.
    What is VERV Investor Sentiment?
    VERV’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of VERV in the last 7 days?
      <0.1% of TipRanks' retail investors changed their holding of VERV in the last 7 days.
        What percentage of retail investors changed their holding of VERV in the last 30 days?
        ▼ 1.3% of TipRanks' retail investors changed their holding of VERV in the last 30 days.
          What is the average age of retail investors who hold VERV?
          The average age of VERV Holders is between 35–55.
            What other stocks have VERV investors also bought?
            VERV Investors also bought PATH, PLUG, XYZ, LCID, RXRX, ISRG, FTNT, TTD, NIO, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALGNAlign Tech
              ALKSAlkermes
              AZNAstraZeneca
              BAXBaxter International
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis